Jim Cramer says stubborn investors are taking the ‘wrong approach’ to the market

Jim Cramer says stubborn investors are taking the ‘wrong approach’ to the market


CNBC’s Jim Cramer on Tuesday warned investors not to be so set in their ways that they miss the chance to make money.

“The level of negativity about stocks at this moment is the highest it’s been in years. … There’s a new class of investors who buy stocks not based on fundamentals, but based on anger, like they’re trying to win some sort of argument. That’s the wrong approach,” the “Mad Money” host said.

“Changing your mind is a virtue in this business,” he added.

Stocks rallied on Tuesday, with the benchmark S&P 500, Nasdaq Composite and Dow Jones Industrial Average closing above their 50-day moving averages for the first time since April. 

Investors believe that the market could be bottoming after its deep downturn this year, fueled by climbing inflation, the Federal Reserve’s series of interest rate increases, the Russia-Ukraine war and Covid lockdowns in China.

Cramer echoed his reminder from earlier this month not to get too fearful over the market’s declines, and added that pessimism didn’t get him anywhere in past financial and economic crises.

“With the benefit of hindsight, my biggest mistake in each case was that I wasn’t bullish enough,” he said.



Source

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
Business

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy

Rear Admiral Erica G. Schwartz. U.S. Department of Health and Human Services President Donald Trump on Thursday nominated Erica Schwartz to serve as director of the Centers for Disease Control and Prevention, concluding a monthslong effort to choose a permanent leader of the embattled health agency.  Schwartz will have to be confirmed by the Senate, […]

Read More
RFK Jr.’s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Business

RFK Jr.’s peptide policy could boost Hims & Hers as its GLP-1 business evolves

Piotr Swat | Lightrocket | Getty Images As its high-margin compounded GLP-1 business evolves, Hims & Hers Health may be finding a new opportunity in peptides. Shares of the telehealth company jumped Thursday after HHS Secretary Robert F. Kennedy Jr. announced Wednesday that the FDA plans to convene a Pharmacy Compounding Advisory Committee meeting to […]

Read More
Netflix reports earnings after the bell. Here’s what to expect
Business

Netflix reports earnings after the bell. Here’s what to expect

The Netflix logo is seen on an office building in Los Angeles, California, on Feb. 5, 2026. Michael Yanow | Nurphoto | Getty Images Netflix kicks off earnings season for media companies on Thursday with a quarterly report that Wall Street hopes will give more updates on the company’s path forward after walking away from […]

Read More